Developed skills and lines of research
Giuseppe Novelli graduated in Biological Sciences in 1981 from the University of Urbino. From 1995 to 1999, he served as an Associate Professor of Human Genetics at the University of Rome Tor Vergata. In 1999, he became a Full Professor of Medical Genetics at the University of Trieste and was later invited to join the Faculty of Medicine and Surgery at Rome Tor Vergata. From 2013 to 2019 he was appointed Rector of this university. Since 2003, Giuseppe Novelli has also been an Adjunct Professor at the University of Arkansas for Medical Sciences in Little Rock, USA. He served as Dean of the Faculty of Medicine and Surgery at the University of Rome Tor Vergata from 2008 to 2011.
Since 2001, he has been the Director of the Medical Genetics Laboratory at the Tor Vergata University Hospital. He has also served as Director of the Medical Genetics Specialization School at the University of Rome Tor Vergata and its partner institutions Sapienza, Chieti, and Bari. Since January 2011, he has been the Scientific Director of the Research Center Fatebenefratelli in Rome at the San Pietro Hospital and has served as Scientific Director of the Molecular Genetics Center at the IRCCS Neuromed Institute since 2012.
Professor Novelli’s current research focuses on the treatment of hereditary diseases, the development of new drugs, and pharmacogenetics. He has coordinated numerous research projects funded by MIUR, CNR, the Ministry of Health, Telethon, AFM, EU FP5, EU FP6, EU FP7, the Ministry of Foreign Affairs, Veronesi Foundation, AIRC, AIFA, ISS, and FFC Ricerca. His name is among the TIS (Top Italian Scientists) listed on via_academy.org.
Projects funded by FFC Ricerca as Principal Investigator or as Research Manager
FFC#23/2006
Causes, evolution and progression of nasal polyps: role of modifier genes and a new approach through CGH array
Publications from FFC Research projects
Sangiuolo F, D’Apice MR, Gambardella S, et al. Toward the pharmacogenomics of cystic fibrosis–an update. Pharmacogenomics. 2004 Oct;5(7):861-78.
Groman JD, Hefferon TW, Casals T, et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet. 2004 Jan;74(1):176-9. Epub 2003 Dec 18.
Gambardella S, Biancolella M, D’Apice MR, Amati F, Sangiuolo F, Farcomeni A, Chillemi G, Bueno S, Desideri A, Novelli G. Gene expression profile study in CFTR mutated bronchial cell lines. Clin Exp Med. 2006 Dec;6(4):157-65.
Corleto VD, Gambardella S, Gullotta F, D’Apice MR, Piciucchi M, Galli E, Lucidi V, Novelli G, Delle Fave G. New PRSS1 and common CFTR mutations in a child with acute recurrent pancreatitis, could be considered an “Hereditary” form of pancreatitis? BMC Gastroenterol. 2010 Oct 15;10:119. doi: 10.1186/1471-230X-10-119.